JOURNAL OF HEART AND LUNG TRANSPLANTATION心肺移植杂志

JOURNAL OF HEART AND LUNG TRANSPLANTATION(英文缩写 J HEART LUNG TRANSPL),ISSN 1053-2498,eISSN 1557-3117,中文译名:心肺移植杂志 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
6.700
JCR 分区
Q1
CAS 分区
B1
近一年发文量
475
本站 PubMed 收录统计

发文量统计区间:2025-09-28 至 2026-09-28,按本站收录文献的发表日期统计。

ISSN: 1053-2498 · eISSN: 1557-3117 · 缩写: J HEART LUNG TRANSPL ·中文: 心肺移植杂志

期刊介绍

选择期刊介绍栏目

期刊简介

《Journal of Heart and Lung Transplantation》是国际心肺移植领域的权威学术期刊,聚焦终末期心力衰竭与肺疾病的移植治疗、机械循环支持及供体管理。内容涵盖临床研究、基础转化与多学科诊疗,读者群主要为移植外科、心衰与肺移植专科医师、免疫学家及重症监护团队。

研究方向

主要方向包括心脏与肺移植的临床结局、免疫抑制策略、排斥反应监测、机械循环支持与体外生命支持、供体评估与保存、移植感染及移植后并发症。论文类型以原创临床研究、注册登记分析、基础与转化研究、综述及指南共识为主。

期刊特色

研究取向强调多中心数据与真实世界证据,重视临床可操作性和长期随访结果。论文通常样本量较大、统计严谨,并关注移植政策与伦理议题。适合心肺移植专科医师、免疫抑制研究者、重症与心衰团队及移植相关护理与药学人员阅读。

投稿难度

投稿难度较高,对创新性、样本规模与统计方法要求严格,临床结局研究需具备充分随访和对照设计。建议提前明确研究问题,完善多中心协作与数据质量,并参考近期同类论文的格式与报告规范,以提升送审与录用机会。

历年影响因子趋势

JCR 数据年份影响因子JCR 分区
202113.569Q1
20228.900Q1
20236.400Q1
20246.000Q1
20256.700Q1

JOURNAL OF HEART AND LUNG TRANSPLANTATION 最新收录文献

  1. JCR分区: Q1 CAS分区: B1 影响因子: 6.7

    1. Perspectives: Consensus Statement Addressing the Practical and Logistical Considerations for Performing Frailty Assessments in Lung Transplant Candidates.

    1. 观点:关于在肺移植候选者中进行衰弱评估的实际操作和后勤考虑因素的共识声明
    作者:
    Michaela Restivo Anderson, Selim M Arcasoy, Christian Benden, Marie Budev, Marlene Cano, Kam Man Larissa Chandra, Malachy J Clancy, Joshua Diamond, Ioannis Dimarakis, Alexander Dragnich, Louise Fuller, Vasiliki Gerovasili, Laurent Godinas, Zubair A Hashmi, Are M Holm, Brittany Koons, Zsofia Kovacs, Jin Gu Lee, Erin M Lowery, Julia Maheshwari, Federica Meloni, Elyn Montgomery, Catherine Myers, Justin Rosenheck, Aman Sidhu, Lianne G Singer, Laurie D Snyder, Syed Tousheed, Rhea Varughese, James R Walsh, Barbara Wilkey, Monique Malouf, Jonathan P Singer
    日期:
    2026-10-01

    该文献暂无摘要。

  2. JCR分区: Q1 CAS分区: B1 影响因子: 6.7

    2. Baseline Lung Allograft Dysfunction: Definition, Timing, and Implications for Outcomes-Perspective on the ISHLT Consensus Document.

    2. 基线肺移植物功能障碍:定义、时机及对结局的影响——对ISHLT共识文件的解读
    作者:
    Jens Gottlieb, Tereza Martinu, Merel Hellemons, David R Darley, Laurie Snyder, Laura DiChiacchio, Miranda Paraskeva, Christian Benden, Berta Saez-Gimenez, Anoop Mohandas, Letizia Corinna Morlacchi, Joshua M Diamond, Saskia Bos, Erika D Lease, Geert Verleden, Allan Glanville, Kieran Halloran
    日期:
    2026-10-01

    该文献暂无摘要。

  3. JCR分区: Q1 CAS分区: B1 影响因子: 6.7
  4. JCR分区: Q1 CAS分区: B1 影响因子: 6.7

    4. Assessing and Addressing Frailty in Candidates for Lung Transplantation: An ISHLT Consensus Statement.

    作者:
    Michaela Restivo Anderson, Selim M Arcasoy, Christian Benden, Marie Budev, Marlene Cano, Kam Man Larissa Chandra, Malachy J Clancy, Joshua Diamond, Ioannis Dimarakis, Alexander Dragnich, Louise Fuller, Vasiliki Gerovasili, Laurent Godinas, Zubair A Hashmi, Are M Holm, Brittany Koons, Zsofia Kovacs, Jin Gu Lee, Erin M Lowery, Julia Maheshwari, Federica Meloni, Elyn Montgomery, Catherine Myers, Justin Rosenheck, Aman Sidhu, Lianne G Singer, Laurie D Snyder, Syed Tousheed, Rhea Varughese, James R Walsh, Barbara Wilkey, Monique Malouf, Jonathan P Singer
    日期:
    2026-10-01

    The ISHLT Consensus document for the selection of lung transplant candidates recommends frailty assessment as part of a comprehensive candidacy evaluation. Missing from this and other recent consensus documents were practical recommendations on which frailty measures to consider and what to do with the information once obtained. In this consensus document, we address practical and logistical issues regarding the assessment and management of frailty in lung transplant candidates.

  5. JCR分区: Q1 CAS分区: B1 影响因子: 6.7

    5. Baseline Lung Allograft Dysfunction: Definition, Timing, and Implications for Outcomes-an ISHLT Consensus Document.

    作者:
    Jens Gottlieb, Tereza Martinu, Merel Hellemons, David R Darley, Laurie Snyder, Laura DiChiacchio, Miranda Paraskeva, Christian Benden, Berta Saez-Gimenez, Anoop Mohandas, Letizia Corinna Morlacchi, Joshua M Diamond, Saskia Bos, Erika D Lease, Geert Verleden, Allan Glanville, Kieran Halloran
    日期:
    2026-10-01

    该文献暂无摘要。

  6. JCR分区: Q1 CAS分区: B1 影响因子: 6.7
  7. JCR分区: Q1 CAS分区: B1 影响因子: 6.7
  8. JCR分区: Q1 CAS分区: B1 影响因子: 6.7

    8. From guideline to practice: Operationalizing telomere length testing in ILD and lung transplantation.

    作者:
    Erica Farrand, Paul J Wolters, Christine Kim Garcia, Chad A Newton
    日期:
    2026-10-01

    The recent International Society for Heart and Lung Transplantation (ISHLT) consensus statement on short telomere syndrome, while focused on lung transplant evaluation, has implications that extend beyond the transplant setting. By formalizing the role of telomere length (TL) testing in transplant care, the consensus has practical implications for clinicians caring for the broader interstitial lung disease (ILD) population. Short telomeres are the most common inherited risk factors for fibrotic ILD and are associated with disease progression, extrapulmonary complications, and increased susceptibility to treatment-related toxicities, including those relevant to immunosuppression and transplant outcomes. As such, TL testing has the potential to inform key clinical decisions, including risk stratification, timing of referral, and peri-transplant planning. Despite this promise, implementation of TL testing in routine practice is limited by the absence of standardized clinical pathways. In this perspective, we do not seek to extend the consensus beyond its stated scope; rather we highlight the practical realities the consensus creates for clinicians caring for patients across the ILD-to-transplant continuum, including who should be tested, when testing should occur, and how results should be interpreted and integrated with genetic and clinical data. We outline major implementation challenges and propose a research agenda to develop intentional, structured, and evidence-based strategies to support the integration of TL testing into ILD and transplant care. TL testing now stands at a critical inflection point; ensuring its responsible, scalable, and equitable implementation will be essential to realizing its potential to improve outcomes across the ILD-to-transplant continuum.

  9. JCR分区: Q1 CAS分区: B1 影响因子: 6.7
  10. JCR分区: Q1 CAS分区: B1 影响因子: 6.7

在 JOURNAL OF HEART AND LUNG TRANSPLANTATION 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊